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Magnetite nanoparticles, especially superparamagnetic iron oxide nanoparticles, are es-
tablished contrast agents for magnetic resonance imaging. Magnetosomes, which are
magnetite nanoparticles of biological origin, have been shown to have better contrast
properties than current formulations possibly because of their larger size and high mon-
odispersity. Here, we present an integrated study of magnetosomes and synthetic mag-
netite nanoparticles of varying size, hence, magnetic properties. We investigate not only
the relaxation times as a measure for the contrast properties of these particles, but also
their cytotoxicity and demonstrate the higher contrast of the larger particles. A the-
oretical model is presented that enables us to simulate the R2=R1 ratio of a contrast
agent and conrm that larger particles oer higher contrast. The results from this study
illustrate the possibility to obtain colloidal stability of large magnetic nanoparticles for
magnetic resonance imaging applications and serve as an impetus for a more quantitative
description of the contrast eect as a function of the size.
1. Introduction. The use of magnetic nanoparticles has developed into a
major research area for bio- and nanotechnologists [1]. Translation to clinical
studies has already started for magnetite nanoparticles in imaging studies among
other application, due to their low toxicity and magnetic properties [2, 3]. Mag-
netic resonance imaging (MRI) is a particularly well-established diagnostic tool for
obtaining images of any space in the human body. The main advantage of MRI
is that it is harmless to the patient while delivering high resolution images of the
body interior.
The magnetic properties of magnetite nanoparticles are dependent on their
size. For equi-dimensional magnetite nanoparticles in the size range from 30 to
100 nm, the particles will be homogeneously magnetized, i.e. have one magnetic
domain. This is referred to as stable single domain (SD) state and is dened by a
high coercive force (Hc). Below 30 nm, the particles are in the superparamagnetic
(SP) state. These are also SD, but the anisotropy energy is suciently low com-
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pared to thermal energy for ipping the magnetic moment of the particle at the
timescale of observation. SP magnetite saturates quickly in elds < 150mT and
has no coercivity.
Contrast enhancement in MRI is achieved by changing the magnetic relaxation
times T1 and T2 of the hydrogen protons contained in the tissue. For MRI, two
dierent classes of contrast agents exist: agents that inuence mainly the signal
in T2  (i.e. negative contrast agents, reducing the signal) or T1  weighted images
(i.e. positive contrast agents, increasing the signal). The degree of the T2 contrast
eect is typically represented by the spin-spin relaxivity R2 = 1=T2, where higher
values of R2 result in a larger contrast eect. Because R2 is strongly related to ,
the magnetic moment of the contrasting nanoparticles, which in turn is dependent
on the size as seen above, it is not surprising that larger particles should provide
enhanced properties as contrast agents relative to smaller ones [4, 5]. However,
an experimental proof obtained on particles of similar batches is lacking as well as
the related theoretical description relating the contrast properties to the particle
size.
SPION (superparamagnetic iron oxide nanoparticles) combine a magnetic core
with a coating agent that is an approved pharmaceutic for contrast agent use in
MRI. Although commercial formulations are already on the market (e.g., Ferumox-
tran for lymph node diagnosis, Feridex or Resovist for liver diagnosis) [2, 6], none
uses biogenic magnetite. SPION are smaller than magnetosomes and by far less
monodisperse than the biological magnetite [7]. Therefore, magnetosomes poten-
tially provide better contrast properties for MRI. Their potential for MRI has been
recognized because they have been shown to possess an even larger R2=R1 ratio
than commercially available contrast agents [8]. However, it is currently not pos-
sible to form magnetosomes in amounts required for pharmaceutical applications
and their cytotoxicity remains to be fully characterized.
We have recently shown that the particle size of magnetite nanoparticles can
be controlled in aqueous-based processes [9] and that particles of dimensions sim-
ilar to those of bacterial magnetosomes can be obtained by this process [10]. In ad-
dition, we have also demonstrated that the dimension of the magnetosome particles
can also be controlled, in this case by genetic engineering [11{13]. Here, we thus
present an integrated study comparing the structural and magnetic properties of
magnetite nanoparticles. We assess their potential as a contrast agent for MRI by
testing not only their relaxation times but also their biocompatibility. In particu-
lar, we test if the high contrast properties obtained for magnetosomes are only due
to their size or if further properties, such as monodispersity or colloidal stability,
are at the origin of this remarkable feature. In addition, we present a method to
calculate the relaxivity of magnetic nanoparticles in MRI. This quantitative de-
scription of the relationship between contrast properties and particle size conrms
the results we obtained experimentally and can be used to assess the theoretical
potential of other particles.
2. Results and discussion. The main ndings from this study can be
illustrated from the results of ve biogenic and six synthetic samples (Table 1).
The samples are categorized as small biogenic (SB), large biogenic (LB), small
inorganic (SI) and large inorganic (LI).
2.1. Structure, size and morphology of the nanoparticles. All samples con-
sist of nanoparticles of pure magnetite, as indicated by the observed peaks in
the X-ray diractogram (Fig. 1) and by diraction maxima measured in SAED
patterns (Fig. 2c,d).
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Fig. 1. X-ray diagram of representative bacteria (LB3 3, orange) and synthetic (LI
2, red) samples as well as reference materials. The salt peak (NaCl) originates from
the drying of the samples and is due to the fact that FeCl and NaOH are used in the
magnetite synthesis.
(a) (b)
(c)
(d)
Fig. 2. (a) A typical view of magnetite nanoparticles in SI1. (b) A HRTEM image of
several nanoparticles, showing euhedral shapes and perfect crystalline structures. (c) A
SAED pattern obtained from a cluster of nanoparticles, and (d) a Fourier transform of
the HRTEM image of particle D in (b). Both the ring pattern in (c) and the intensity
maxima in (d) can be indexed according to the structure of magnetite.
2.1.1. Synthetic samples. The size of the individual nanoparticles ranges from
a few to several tens of nanometers (Table 1). The mean sizes determined by TEM
for the particles in the SI samples are in good agreement with the sizes obtained
using synchrotron X-ray diraction. The size of larger particles (LI samples) is
dicult to determine from TEM micrographs because of aggregation.
All synthetic samples are very similar in that they contain clusters of nan-
oparticles in random orientations (Fig. 2a), with most particles having euhedral
(octahedral or cuboctahedral) shapes and typically perfect structures (Fig. 2b), as
suggested by high-resolution TEM images. SAED patterns obtained from both
clusters of crystals (cf. ring patterns in Fig. 2c) and from individual nanoparticles
are consistent with the structure of defect-free magnetite (Fig. 2d).
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The particle size distribution of SI1 has a maximum at 15 nm, but extends to
approximately 30 nm (Supplementary Fig. 1), LI2 and LI3 also consist of mostly
small (15 nm) magnetite nanoparticles; however, these samples also contain lar-
ger aggregates that apparently formed from randomly or similarly oriented nano-
crystals.
2.1.2. Biological samples. In all biological samples, the magnetosomes ex-
tracted from dierent strains of the magnetotactic bacterium Magnetospirillum
gryphiswaldense (Table S1) are still enveloped by the magnetosome membrane.
This surface layer prevents clustering/aggregation of the particles and results in
a dispersed distribution of magnetosomes on the TEM grid. Typically, particles
larger than 30 nm in diameter form chains, whereas smaller particles appear ran-
domly scattered (Fig. 3).
Compared to magnetosomes of the wild-type, particles of mutant strains
(LB2) show a dierence in both particle size and shape. This mutation is not
expected to alter the physico chemical properties of the particles except their
size and shape. Whereas the wild-type particles produce a negatively-skewed size
distribution, size distributions in mutant samples are lognormal-like (SB2), Gaus-
sian (SB1 and LB3) or broad, double-peaked (LB1) (Fig. 3b). The mean size of
the distributions increases from 23.6 nm (SB1) to 41 nm (LB1). Concerning the
shapes of the particles, samples LB2 and SB2 contain wild-type-like, mostly single
crystalline, euhedral particles (Fig. 4a).
The shape factor distribution is relatively narrow in these samples and re-
sembles the curves that are typically obtained for magnetosomes from the wild-
type (Fig. 3c). In the other samples, however, a large fraction of the magnetosomes
is either twinned or multiply aggregated. This eect is most pronounced in the
case of SB2 which contains relatively large crystals, most of which are composed of
several crystallites (Fig. 4b). The aggregated nature of the magnetosomes clearly
aects their shape factor distribution because samples containing a large fraction
of twinned or aggregated particles produce broad shape distributions (Fig. 3c).
The TEM-based particle size and shape measurements are entirely consistent with
the bulk magnetic data as shown below.
2.2. Magnetic properties. Biological samples show a large variation in their
magnetic properties (Table 1). SB1 has a closed hysteresis loop, which would be
(a) (b)
Fig. 4. HRTEM images of (a) a single-crystal magnetosome with a perfect structure
from SB2, with the Fourier transform of the image in the lower left, indicating that
the crystal is viewed along the [223] crystallographic direction, and (b) an aggregate
magnetosome that consists of at least three individual crystals, from sample LB3.
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Fig. 5. Normalized hysteresis loops for chemically synthesized and biologically miner-
alized magnetite nanoparticles with the average particle size in the (a) SSD and (b) SP
domain.
expected for true SP behavior (Fig. 5). The hysteresis loops of the other biological
samples are open, and the ratios of remanent saturation magnetization to satura-
tion magnetization (Mrs=Ms) and remanent coercivity to coercivity (Hcr/Hc) are
compatible with a mixture of SD and SP particle sizes. All synthetic samples
show an open hysteresis loop (Fig. 5). The magnetization ratio is variable and
suggests a SD particle size with a signicant SP contribution. The approach to
saturation magnetization of synthetic particles is slower (low susceptibility) and
requires much higher elds to reach saturation if compared to biological particles.
First order reversal curve (FORC) analysis is a powerful technique for char-
acterizing ferromagnetic minerals (s.l.), their domain state (SP and SD), and the
extent of interactions between particles [14{17]. FORC distributions located near
the origin, i.e. at the cross-section of the interaction axis (Hb) and the coercivity
axis (Ha), with an upward oset signify non-interacting particles, whereas a spread
along Ha signies a distribution in particle size. A spread along Hb on the FORC
diagram indicates the presence of interacting SD particles. FORC diagrams for
SB1, SB2, SI1, and SI2 reveal the dominance of magnetite nanoparticles that are
SP (Fig. 6). The other samples contain a broader mixture of SP and SD particle
sizes.
Decomposing the FORC measurements into the reversible and irreversible
parts of the induced magnetization clearly shows the relative magnitudes of the
SP and SD contributions (Fig. 7) [18]. Samples LB1, LB2, LI2, LI3, and LI4 have
a larger contribution of irreversible magnetization, i.e. the SD particle size. LB3
has less of the contribution from SD particles, and samples SB2, SI1 and SI2 are
largely SP. Only SB1 is almost purely SP in its magnetic behavior.
From FORC analysis one sees that the biological SD samples exhibit a lower
spread on the Hb (interaction) axis, varying between 15mT, if compared to the
synthetic samples that range from 30mT to +40mT. This suggests a lower degree
of the interaction among magnetite particles from biologic origin if compared to
chemically synthesized ones. There is also a larger spread in coercivity distribution
of the synthetic samples, e.g., it ranges from 0mT to 40mT for SI1 with the
smallest particle size distribution if compared to SB1. It should be noted that
the larger degree of interactions in the synthetic samples may lead to a larger
eective magnetic particle size in comparison to their physical size, i.e. aggregates
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of SP particles behave like the SD size. Afterward SI1 was coated with L-3,4
Dihydroxyphenylalanin (L-DOPA) (SI1s) which inhibited the particle interaction.
The FORC distribution is concentrated at the origin, as would be expected for
purely SP particles, and the magnetization is largely reversible (Supplementary
Fig. 2), similar to what is found for SB1. Resovist shows a largely reversible
magnetization similar to what is seen in SI1s and SB1 (Supplementary Fig. 3).
Truncating the FORC distribution to suppress the very low coercivity, however,
shows that there are particles with a higher coercivity (cf. inset Supplementary
Fig. 3). This higher coercivity tail is not found in SB1 and SI1s.
In summary, FORC analysis demonstrates that the magnetic properties of
samples SB1, SB2, SI1 and SI2 are dominated by the SP fraction in the sample.
Samples LB1, LB2, LB3, LI2, LI4 and LI4 may also have SP particles, but the
SSD particles dominate. Coating the synthetic particles is successful in breaking
down the particle interaction, so that their magnetic properties are SP.
2.2.1. Biocompatibility. The biocompatibility of the synthetic and biological
samples was tested by dierent assay systems: EZ4U and LDH assays, using
various cell lines: MC3T3-E1 osteoblast, NIH3T3 broblasts and RAW264.7 mac-
rophages (Table 1). IGC50 values obtained by the EZ4U and LDH assays give
similar results for all synthetic and biological samples within one cell line. More
specically, IGC50 values of the synthetic particles, which were determined in
the three cell lines, range from 0.15 { 0.65mg/ml in the case of EZ4U assay and
between 0.20 { 0.65mg/ml in the case of LDH assay. These results demonstrate
that IGC50 values of the synthetic particles with sizes between 17 { 36 nm do not
depend on the size.
The biocompatibility of numerous types of articially synthesized nanoparticles,
e.g., chitosan, silica and zinc oxide, has been determined using various cell lines
[19 { 22]. IGC50 values of 0.1 { 0.25mg/ml were reported for iron oxide nano-
particles [23, 24]. The IGC50 values from this study are not broader and only
slightly higher than values reported in these investigations and show that the cyto-
toxicity of our synthetic inorganic iron oxide particles is comparable to synthetic
particles from, e.g., chitosan or zinc oxide.
The IGC50 values of the biological particles show a larger variation than those
of synthetic particles. They are, however, similar within one cell line. IGC50 values
evaluated by EZ4U and LHD assays in MC3T3-E1 and RAW264.7 cells range from
0.05 to0.19mg/ml and 0.07 to0.43mg/ml, respectively. In NIH3T3 cells, IGC50
values are higher than in the other two cell lines, which cannot be explained at
present. IGC50 value in NIH3T3 cells, determined by EZ4U and LDH assays,
range from 0.48 to 0.94mg/ml. Thus, the applied genetic manipulation of the
biological nanoparticles did have an eect on the IGC50 values in the tested cell
lines. In general, the synthetic particles are less toxic to the cells than the biological
ones, probably due to the presence of remaining bacterial cell components on the
magnetosome membrane.
2.3. Colloidal stability. The biological samples were found to be colloid-
ally stable without further stabilization. This behavior can be attributed to the
magnetosome's membrane, which is sucient to stabilize the particles in aqueous
media. The synthetic particles, on the other hand, specically those exhibiting
large crystal sizes and hence high magnetic attraction forces, are prone to aggreg-
ation. Thus, stabilization is essential for these nanoparticles because a surface
modication during the synthesis step is missing.
Particles can typically be colloidally stabilized using two dierent approaches:
electrostatic or steric stabilization. Iron oxide nanoparticles for biomedical applic-
ations are typically sterically stabilized by using biocompatible dispersants, such
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as dextran [25], polyethylene glycol [26] or poly (vinyl alcohol) [6]. These dispers-
ants are physically adsorbed on the particle surface and prevent the particles from
aggregation due to steric repulsion. Because non-ionic stabilization polymers do
not lead to any colloidally stable dispersion, cationic polymers, such as polyethyl-
enimine (PEI) and chitosan, were found to be good dispersants for the synthetic
particles (data not shown). PEI and chitosan are known to oer an exceptionally
strong adhesion because of additional ionic interactions with the particle surface
[27]. Electrostatic stabilization, in turn, can be achieved by introducing an an-
ionic/cationic charge [6] either due to anions/cations or due to monomers with a
charged functional group, i.e. citric acid [28]. The most promising results were
obtained using L-DOPA, which is known to exhibit high anity anchor groups for
iron oxide particles that leads to highly stable dispersions [29].
The stabilization of the synthetic particles LI1, SI1, and SI2 was successful,
and the stabilized dispersion of SI2s using L-DOPA is exemplary shown in Fig. 8.
The change in colloidal stability can be clearly visually observed and is also reec-
ted by the hydrodynamic diameter which is in the range of 100 { 125 nm after the
stabilization. The stabilized particles show good colloidal stability until present,
six months after treatment. Stabilization of the samples LI2, LI3 and LI4 was not
successful. This can be attributed to the larger core sizes which lead to stronger
magnetic interaction (i.e. larger contribution of irreversible magnetization, cf.
Fig. 7), which results in irreversible aggregation.
2.4. MRI relaxivity. In general, paramagnetic and superparamagnetic sub-
stances lead to a shortening of the relaxation times T1 (spin{lattice relaxation time)
and T2 (spin-spin relaxation time) of the hydrogen protons in the surrounding tis-
(a) (b)
(c)
SI2
SI2s
I
,
[a
.u
.]
dh
Fig. 8. Sample SI2 (a) before and (b) after stabilization using L-DOPA. The log-normal
distribution of the hydrodynamic diameter (c) of the original and stabilized particles
clearly indicates the stabilization eect.
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Fig. 9. Concentration dependent relaxation rates (a) 1=T1 (R1) and (b) 1=T2 (R2)
determined at 0.94T and 39C. Biological particles are represented by squares and
synthetic particles are represented by triangles, respectively.
sue. Iron oxide nanoparticles exhibit an especially strong shortening of T2, for
which they are also called T2-contrast agents. The higher the shortening of T2,
which is equivalent to a high R2 relaxivity, the higher the obtained T2 weighted
contrast. Contrast agents, in general, are characterized by the ratio of the relaxiv-
ity R2=R1. Therefore, a high T2 weighted contrast can be obtained by combining
high R2 values with low R1 values. In order to investigate the potential suitability
of the particles as contrast agents in MRI, the relaxation times were measured and
compared with the known contrast agent Resovist.
Fig. 9 illustrates the relationship between the relaxation rates 1=T1 and 1=T2
and iron concentration. As expected, both relaxation rates increase with increasing
iron concentration. The relaxation rates of all particles show good linearity in the
measured concentration range, which is an indication for non-interacting particles
and colloidal stability. Colloidal stability is mandatory for the determination of
the relaxivity values R1, R2 and R2=R1.
The dependence of the relaxivity on the core diameter dc of dierent particles
is shown in Fig. 10. Independent of the origin of the particles, biological or syn-
thetic, the R2 relaxivity increases roughly linearly with the core diameter dc. The
increase of the R2 relaxivity with the particle size can be explained by the fact
that larger particles exhibit stronger magnetic moments, which leads to a faster
dephasing of the hydrogen protons and, therefore, to a stronger shortening of T2.
It is known that the T2-eect dominates for iron oxide particles over the T1-eect.
We also observe a slight dependence of R1 on the size: a decreasing T1 eect is
obtained for increasing core diameter. Considering the R1 and R2 relaxivities, the
decisive R2=R1 ratio increases with the core diameter.
It has to be noted that in addition to the dependence of the relaxation prop-
erties on the core diameter dc, a strong dependence was also found on the hy-
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Fig. 10. Size dependence (dc) of the R1 relaxivity (square), R2 relaxivity (circle)
and the ratio R2=R1 (triangle). Biological particles are represented by lled symbols and
synthetic particles are represented by blank symbols, respectively.
drodynamic diameter dh (data not shown). Therefore, only particles with similar
hydrodynamic diameters can be compared directly (see Table 1).
The biological particles were measured in the original state because of their
sucient colloidal stability. Compared to Resovist, the smallest biological particles
SB1 (dc = 24nm) exhibit a 1.5-fold increase in R2 and a 3.2-fold increase in R2=R1.
In accordance with the observed size-dependence, the large biological particles
LB2 (dc = 38nm) show an improved relaxation behavior with a 2.2 fold higher
R2 relaxivity and, due to the low R1 relaxivity, even a 4.9-fold higher R2=R1
relaxivity.
The relaxation properties of the original synthetic particles could not be
measured because of colloidal instability; therefore, only the L-DOPA-stabilized
particles were used for the determination of the relaxation properties. The R2 re-
laxivity is increased compared to that of Resovist, but, due to the overall smaller
core diameters, only to a limited degree. The SI2s particles with the smallest core
diameter (dc = 18nm) showed a 1.4-fold increase in R2 and a 1.8-fold increase in
R2=R1. The observed size dependence also applies to the synthetic particles, where
the sample LI1s with a larger core diameter (dc = 28nm) showed enhanced relax-
ation eects. Accordingly, LI1s provided a 2.5-fold increase of R2=R1 compared
to Resovist.
This study was focused on the determination of the MRI relaxation times
and showed the advantage of larger particles in T2-weighted imaging. Besides the
relaxation times, for a successful use of the particles in vivo and for an extensive
description of the contrast properties, aspects like blood half-life, biodistribution,
clearance properties and particle surface characteristics, are all expected to play
an important role. The blood half-life is closely connected with the uptake process
into the mononuclear phagocyte system (MPS) and is faster for larger particles.
[30, 31] For this reason, the larger particles may not be perfectly suited, despite the
best relaxation properties, the particles may not be perfectly suited in applications
where a long blood half-life is needed (e.g., angiography). In this case, smaller
particles with less enhanced relaxation properties are preferred. On the other
hand, the large particles can be used for applications where a fast uptake by
the macrophages (MPS) is preferred, e.g., liver/spleen imaging or macrophage
associated inammation imaging [32, 33]. In addition, dierent surface coatings
of the biological and synthetic particles (magnetosome membrane vs. L-DOPA
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coating) may inuence the blood kinetics and aect the in vivo behavior of the
particles [34]. These examples show that not only the relaxation properties of the
particles are decisive for a new MRI imaging agent, but also aspects concerning
the particle behavior in vivo have to be taken into account. An extensive in vivo
characterization of the particles investigated in this study will be the subject of a
future work.
2.5. Simulation of contrast properties. In order to better understand factors
that aect relaxivity in a particle system, a model has been developed to calcu-
late changes in relaxivity by varying dierent physical parameters, such as the
core and hydrodynamic diameters, the particles magnetization and its anisotropy,
external eld strength, or the ratio between \inner" and \outer" viscosities. Ex-
pressions for the longitudinal T1 and transversal T2 relaxation times of protons
are derived from a semi-classical model, where the protons are described in the
frame of quantum mechanics, and magnetic nanoparticles are treated classically as
macroscopic objects. Magnetic nanoparticles create random magnetic elds acting
on the protons. Their randomness originates rst from the distance between the
nanoparticle and the proton, which is random due to thermal diusion of water
molecules, and second due to thermal uctuations of the magnetic moment of the
particle. As a result, the longitudinal and transversal relaxation times of the pro-
ton are expressed through time correlation functions of the magnetic moment of
the nanoparticle and through the function j [35] describing the thermal motion of
the proton in the vicinity of the nanoparticle.
Time correlation functions of the magnetic moment are calculated using the
\egg-yolk" model [36], which takes into account the simultaneous Brownian rota-
tion of the particle (\egg") and the magnetic moment (\yolk"). The model accepts
three non-dimensional parameters corresponding to external eld strength, aniso-
tropy of the particle, and ratio of \inner" and \outer" viscosities of the particle.
These parameters can be calculated from the physical parameters of the system
as follows:
 =
H
kBT
;  =
KVm
kBT
;  =
m
B
;
where  is the magnetic moment of the particle, H the external magnetic eld, kB
the Boltzmann constant, T the temperature, K the magnetic anisotropy constant
of the particle, Vm the magnetic volume of the particle, and m and B the char-
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
Fig. 11. Correlation decay times in the weak eld limit ( = 10 2) of magnetic
moment components parallel (blue) and perpendicular (red) to the anisotropy axis of the
particle. Numerical simulation was performed with  = 0:5 (circles) and  = 1 (squares).
Lines represent the theoretical expressions [37].
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Fig. 12. Correlation decay times in the rigid dipole limit ( = 103) of magnetic moment
components parallel (blue) and perpendicular (red) to the external eld. Numerical
simulation (circles) is compared to theoretical expressions (lines) [38].
acteristic rotational diusion times of the \yolk" and the \egg", respectively. In
the limits of a weak eld and a rigid dipole, the time correlation functions may be
well approximated by single exponentials. The decay times of these exponentials
are in good agreement with theoretical expressions, as shown in Figs. 11 and 12.
For an intermediate range of magnetic eld strength and magnetic anisotropy,
the time correlation functions should be approximated by sums of exponentials as
follows:
zz0 = 
2
 
C2z;0 +
X
k
Cz;k e
 =z;k
!
;
xx0 = yy0 = 
2
X
k
Cxy;k e
 =xy;k :
Numerical simulation gives correct values for the mean-square uctuation of z,
namely, X
k
Cz;k = 1  2L()

  L2();
where L() is the Langevin function. Fig. 13 shows two decay times of z , z0
at intermediate values of anisotropy and external eld. They result from contri-
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Fig. 13. Numerically computed decay times (circles) of z , z0 with  = 5,  = 0:1.
As a comparison, the theoretical decay time of the rigid dipole is shown (line). Squares
represent the theoretical decay times for the magnetic moment components parallel (blue)
and perpendicular (red) to the anisotropy axis of the particle [37].
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butions of the magnetic moment components parallel and perpendicular to the
particles anisotropy axis, leading to a slow and a fast decay time, respectively.
As a result for the longitudinal (T 11 = R1c) and transversal (T
 1
2 = R2c)
coecients of the relaxivity R1;2 (c is the molar concentration of iron in the
sample), we obtained [39]:
R1 = A
"
6C2z;0 j(i!ID) + 6
X
k
Cz;k j

i!ID +
D
z;k

+14
X
k
Cxy;k j

i!ID +
D
xy;k
#
;
(1)
R2 =
R1
2
= A
"
4C2z;0 + 4
X
k
Cz;k j

D
z;k

+ 6
X
k
Cxy;k j

D
xy;k
#
; (2)
where
A =
162IM
2
s MVm
135DRnFe
;
and
j(z) = <e
(
1 + 14z
1=2
1 + z1=2 + 49z +
1
9z
3=2
)
;
and where I is the proton gyromagnetic ratio, Ms the saturation magnetization
of the particle,  the density of the particle, M the molar weight of mineral that
constitute the particle, D the self-diusion coecient of water molecules, R the
radius of the particle, nFe the number of magnetic atoms in the formula unit of
the constituting material, and D = R
2=D is the characteristic diusion time of
the proton in the vicinity of the particle.
The model described by relations (1) and (2) was checked with existing exper-
imental data. The relaxivity coecient R2 increases linearly with the size of the
nanoparticle according to [40]. This result is in agreement with relation (2). It is
known that the relaxivity of the nanoparticles R1 exhibits maximum as a function
of the external magnetic eld strength. It attens out with the increase of the
particle size or magnetic anisotropy constant, as shown in [41] by comparison of
10
-3
10
-2 -1
100
250
300
200
10
50
150
10
0
10
1
10
2
R
1
,
[L
/
(m
m
o
ls
)]
f , [Hz]
Fig. 14. Numerical simulation of R1 with dierent magnetic anisotropy constants.
K = 103 (blue line), K = 5  103(green line) and K = 104(red line). Other parameters
of the simulation are " = 0:0043, core and hydrodynamic diameters of the particle dc =
dh = 20nm , T = 312K, Ms = 300 kA/m,  = 6:7  10 4 Pas, M = 0:23 kg/mol,
 = 5:15 g/cm3, nFe = 3.
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the relaxivity data for maghemite and cobalt ferrite nanoparticles. Our numerical
simulation conrms this behavior, as shown in Fig. 14. The veried model was
applied to the experimental data.
Experimental data for various synthetic inorganic and biological samples are
shown in Table 1. Numerical simulations were performed to compute relaxivities
using the model and are shown in Table 2. The physical parameters of the particles,
i.e. core diameters and eld of saturation magnetization were chosen to reect
values obtained from the real particles. An exception was the hydrodynamic size
of the particle that was kept close to the magnetic core size, with only a small
(2.5 nm) non-magnetic layer. This characterizes the ability of water molecules to
enter the non-magnetic coating layer. Use of the measured hydrodynamic size leads
to modeled relaxivity values that are in disagreement with experimental values.
To demonstrate the eect of saturation magnetization Ms on relaxation para-
meters, various values were used in numerical simulation and the results are
shown in Figs. 15 { 17. Other parameters were kept the same, as in Table 2,
and dh = dc + 5nm. Both R1 and R2 increase with Ms, as expected by relations
(1) and (2), but their ratio is invariant. In general, the numerical model predicts
that at a constant external eld (0.94T) the most important physical parameters
of the particles are their magnetic core size and saturation magnetization as these
parameters change the relaxivities the most. Eects from other parameters are
small or vanishing.
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Fig. 15. Comparison of R1 measured at 0.94T (markers) with those computed
numerically for various values of magnetization (lines).
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Fig. 16. Comparison of R2 measured at 0.94T (markers) with those computed
numerically for various values of magnetization (lines).
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Table 2. Results of numerical simulation. Common parameters: magnetite particles in
water, anisotropy energy density K = 10 kJ/m3, B = 0:94T, T = 39 C. Here " is the
ratio between \inner" and \outer" viscosities of the nanoparticle [4].
Sample dc dh Ms " R1 R2 R2=R1
[nm] [nm] [kA/m] [L/mmols] [L/mmols]
SB1 24 29 300 0.0024 11.9 234 19.7
LB1 41 46 300 0.0030 8.1 723 89.3
LB2 38 43 300 0.0029 8.7 617 70.9
SB2 29 34 300 0.0026 10.8 349 32.3
LI1s 28 33 357 0.0031 15.7 460 29.3
SI1s 17 22 358 0.0023 17.5 160 9.1
SI2s 18 23 329 0.0022 14.9 153 10.3
3. Conclusions. This multidisciplinary study shows that stable magnetic
nanoparticles with a limited size distribution can be produced either biologically
or synthetically, with particle size distributions being narrower for the biological
samples. Small particles exhibit predominantly SP behavior, whereas the mag-
netic properties of samples consisting of larger particles show a combination of
SP and SD behavior. Stabilization of the synthetic, inorganic particles prevents
aggregation, so that small particles are almost exclusively SP in their magnetic
properties.
Both types of particles, the biological as well as the synthetic ones, provide
enhanced relaxation properties compared to the known MRI contrast agent Reso-
vist. A signicantly larger particle core diameter leads to a higher R2 relaxivity.
Combined with a low R1 relaxivity, the R1=R2 relaxivity values of these particles
are highly improved. Due to the insucient colloidal stability of the large synthetic
particles, only the small particles were investigated. These particles oer enhanced
contrast properties with respect to Resovist but reduced contrast compared to the
biological magnetosomes. A comparison to the MRI relaxivity that was measured
for the particles with the simulated values shows the same trend in R2=R1 as a
function of the particles size. Therefore, this model can aid further in exploring
which physical properties of a material, such as core particle size, hydrodynamic
diameter, or Ms, will lead to improved contrast properties. No enhanced toxicity
was found for larger particles, while higher toxicity was measured for biological
particles. Therefore, combining size eect, colloidal stability and low toxicity with
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improvements in the stabilization of the synthetic particles, in particular, of those
with the large core diameter, has the potential of providing particles with enhanced
relaxation properties without problems associated with toxicity.
4. Materials and methods. We produced and analyzed 50 bacterial and
80 synthetic samples of magnetite nanoparticles. Procedures of the production of
both biogenic and synthetic samples were continually rened in response to the
results of sample characterization, in order to achieve the highest purity magnetite
and the best performance of the particles as MRI contrast agents. We exemplify
our ndings on typical samples presented in Table 1.
4.1. Magnetite synthesis. Magnetite nanoparticles were synthesized by the
modied co-precipitation method [9, 10]. Briey, the system was controlled by a
titration set-up (Metrohm, 776 Dosimat and 719 S Titrino). The iron was added
as FeII=FeIII-chloride solutions (1M, FeII=FeIII = 1=2) at a rate of 1l/min to a
total volume of 10ml. The pH and the temperature were kept constant during the
process (pH=9 0.4 or 11 0.1 with 1M NaOH; temperature= 25 0.1 C). All
solutions were degassed before using and the system was kept under a nitrogen
atmosphere during the synthesis.
4.2. Stabilization of synthetic particles. The colloidally unstable particle
dispersion was treated with an ultrasonic tip (Bandelin Sonoplus, duration=30 s
with 60% power) to reduce the size of large particle aggregates. Afterwards, the
particle dispersion was mixed 1/1 (v/v) with a 10wt% polymeric solution and a
saturated solution of L-DOPA, respectively. The solution was shaken for 3 h (Ther-
momixer comfort, Eppendorf) and nally centrifuged (Biofuge pico, Heraeus) for
5min at 4000 rpm. The resulting supernatant, containing the stabilized particles,
was removed and analyzed in terms of the particle size (DLS) and iron content.
4.3. Magnetosome formation, isolation and preparation. For the formation
of biogenic magnetite particles, Magnetosprillum gryphiswaldense wild-type and
mutant strains (Table S1) were grown anaerobically at 25C in a 30 L Biostat C
fermentor (B.Braun Biotech International, Melsungen, Germany) using a modied
ask standard medium [42]. Cells were harvested after 24 { 36 h by tangential ow
ltration and centrifugation (9250 g, 15min, 4 C). Pelleted cells were resuspended
and washed twice in an ice-cold wash buer (20mM Hepes, 5mM EDTA, pH7.4).
Subsequently, cell pellets were stored at {20 C until use. For magnetosome isola-
tion, cells were resuspended in 50 mM Hepes, 1mM EDTA, 0.1mM PMSF, pH7.4
(7ml per g fresh weight) and disrupted by 3 passages through a Microuidizer
M110-L system equipped with a 100m HZ10 diamond interaction chamber. After
removal of cell debris by centrifugation (1000 rpm, 10min, 4 C), the supernatant
was subjected to magnetic separation, as described earlier [43]. The resulting en-
riched magnetosome suspension was applied on a 50% (w/w) sucrose cushion and
centrifuged at 230 000 g at 4 C for 2 h. Finally, the supernatant was removed, the
pelleted magnetosomes were resuspended in 10mM Hepes, 1mM EDTA, pH7.4
and subsequently stored under an inert nitrogen atmosphere at 4 C in order to
prevent oxidation.
4.4. X-ray diraction. The particles were analyzed, as previously described
[10, 44]. Briey, the material was dried with an -quartz standard [23] on a Kapton
thin lm and measured in transmission with a 100m beam at a wavelength
  0:82656A at the -Spot beam line of the BESSY II synchrotron radiation
facility, Berlin [45]. The particle size was determined by Scherrer analysis, i.e.
by tting the (311) peak with a pseudo-Voigt function and after correcting for
instrumental peak broadening [26].
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4.5. Transmission Electron Microscopy. The nanoparticles were deposited
from a suspension onto Cu transmission electron microscopy (TEM) grids covered
with either lacey or continuous Formvar+carbon lms. Bright-eld and high-
resolution (HRTEM) images, as well as selected-area electron diraction (SAED)
patterns were obtained using a JEOL 3010 transmission electron microscope op-
erated at 300 kV accelerating voltage and equipped with a Gatan Imaging Filter
for the acquisition of energy-ltered elemental maps. Images were recorded on
a CCD camera. Additionally, bright-eld images and SAED patterns were also
recorded on imaging plates using a Philips CM20 TEM operated at 200 kV. For
the processing and interpretation of data, we used the Digital Micrograph and
SingleCrystal software.
4.6. Magnetic measurements. All magnetic measurements were made using
a Princeton Measurements Corporation, Vibrating Sample Magnetometer (VSM;
Micro-Mag Model 3900) at room temperature. Hysteresis loops were measured
under a maximum applied eld of 1T with 100ms averaging time and variable
measurement spacing. FORC measurements were made by rst saturating the
sample with a positive applied eld of 1T and then ramping down the eld to
a reversal eld (Hr), followed by measuring magnetization as the eld increases
from reversal eld back to positive saturation. A series of 140 FORC with a eld
spacing of 2.4mT was used for the analysis. FORC data were transformed into
FORC diagrams using M.Winklhofer MATLAB code [46]. FORC diagrams were
processed with a smoothing factor of 2.
4.7. Biocompatibility tests. The following various cell lines were used to de-
termine IGC50 values of magnetic nanoparticles (MNPs): NIH3T3 (broblasts),
MC3T3-E1 (osteoblasts) and RAW264.7 (macrophages). These cells were cul-
tured in Dulbecco's modied eagles medium (DMEM) with 10% fetal bovine serum
(FBS) and 50g/ml gentamycin. Cultures were performed under a humidied at-
mosphere at 37 C and 5% CO2. For experiments, the cells were seeded in DMEM
with 2% FBS and 50g/ml gentamycin at a density of 2  104 cells cm 2 in a
96-well plate. After 24 hours of cultivation, the culture medium was changed and
inorganic samples or biological samples were added to the cells, followed by an in-
cubation time of 72 hours. The IGC50 values were calculated from dose-response
curves ranging from 0.005 to 2mg/ml inorganic or biological samples cm 2 ac-
cording to Lee et al. by using nonlinear least-squares analysis [47]. For identifying
IGC50 values, two dierent biochemical assays were used. First was the EZ4U as-
say (colorimetric MTT assay; Biomedica, Austria) which is based on the principle
that living cells reduce uncoloured tetrazolium salts into intensely coloured form-
azan derivates that requires functional mitochondriae. Second was the CytoTox
ONE Membrane Integrity assay (Promega) which measures lactate dehydrogenase
(LDH) release that is based on the conversion of resazurin into resorun. Because
MTT and LDH assays are colorimetric assays, MNPs and BMGs were removed
prior to the incubation with the assay substrates to prevent optical interference
[48].
4.8. Relaxation times. The relaxation times of the magnetic nanoparticles
were determined using a Bruker mq 40 contrast agent analyzer (0.94T at 40MHz).
The relaxation times T1 and T2 in [ms] were measured at 39
C using aqueous
particle dispersions of 0.1, 0.25 and 0.5mM iron, respectively. The relaxivities R1
and R2 in [L/(mmols)] were determined by applying the linear relationship of the
reciprocal of the relaxation time 1=T1;2 in [s
 1] and the iron concentration c(Fe) in
[mM]. Finally, the relaxivity R1;2 was dened by the slope of the obtained linear
equation.
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4.9. DLS. Dynamic light scattering (DLS) was used to characterize the
colloidal stable particles in terms of their size. The hydrodynamic diameter dh
was measured with a Submicron Particle Sizer Model 370 from Nicomp Particle
Sizing Systems.
4.10. Iron concentration measurements. The iron content was measured
using a UV/VIS phenanthroline assay. Briey, hydrochloric acid was added to
a dened volume of the particle suspension in order to dissolve the iron oxide
particles. Afterwards the iron ions were reduced to Fe2+ by following complexation
with 1,10-Phenathroline. The iron content was determined by using the linear
relationship of absorbance and iron concentration (using calibration standards).
This multidisciplinary study shows that stable magnetic nanoparticles with
a limited size distribution can be produced either biologically or synthetically,
with particle size distributions being narrower for the biological samples. Small
particles exhibit predominantly SP behavior, whereas the magnetic properties of
samples consisting of larger particles show a combination of SP and SD behavior.
Stabilization of the synthetic, inorganic particles prevents aggregation, so that
small particles are almost exclusively SP in their magnetic properties.
Both types of particles, the biological as well as the synthetic ones, provide
enhanced relaxation properties compared to the known MRI contrast agent Reso-
vist. A signicantly larger particle core diameter leads to a higher R2 relaxivity.
Combined with a low R1 relaxivity, the R2=R1 relaxivity values of these particles
are highly improved. Due to the insucient colloidal stability of the large synthetic
particles, only the small particles were investigated. These particles oer enhanced
contrast properties with respect to Resovist but reduced contrast compared to the
biological magnetosomes. A comparison to the MRI relaxivity that was measured
for the particles with the simulated values shows the same trend in R1/R2 as a
function of the particles size. Therefore, this model can aid further in exploring
which physical properties of a material, such as core particle size, hydrodynamic
diameter, or Ms, will lead to improved contrast properties. No enhanced toxicity
was found for larger particles, while higher toxicity was measured for biological
particles. Therefore, combining size eect, colloidal stability and low toxicity with
improvements in the stabilization of the synthetic particles, in particular, of those
with the large core diameter, has the potential of providing particles with enhanced
relaxation properties without problems associated with toxicity.
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Fig. 18. Size distribution of particles in SI1 as measured from TEM images.
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Fig. 19. (a) FORC diagram; (b) FORC diagram suppressing coercivity < 10mT; and
(c) derivatives of the magnetic moment showing reversible (blue) and irreversible (red)
components of magnetization for the synthetic inorganic sample SI1s.
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Table 3. Bacterial strains used in this study.
Sample
identier Strain Important feature(s) Reference
SB1 M. gryphiswaldense F3D R3/S1 with deletion Suppl. Ref. 1
of all mamF=mmsF
LB1 M. gryphiswaldense mms48 R3/S1 mms48 Suppl. Ref. 2
LB2 M. gryphiswaldense R3/S1 Wildtype, but Suppl. Ref. 3
Rif r Smr
SB2 M. gryphiswaldense Fe4 R3/S1 with mutations Suppl. Ref. 1
in iron uptake genes
LB3 M. gryphiswaldense A11 R3/S1 mamGFDC Suppl. Ref. 4
and mamXY operon
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